Beximco Pharma donates Remdesivir to Bangladesh Government

Beximco Pharma donates Remdesivir to Bangladesh Government On 21 May 2020, Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”), received Emergency Use Authorization for its Remdesivir IV Injection (under the brand name Bemsivir) from Directorate General of Drug Administration (DGDA). With this approval and product launch on the same day, Beximco Pharma became the first in the world to launch a generic version of this highly anticipated drug, which is also the first to be found effective in stopping the replication of SARS-CoV-2.

On the very first day of receiving regulatory approval, Beximco Pharma has donated large quantities of Remdesivir (Bemsivir) to Bangladesh Government for the treatment of COVID-19 patients.

Nazmul Hassan MP, Managing Director, Beximco Pharma, handed over the medicine to Mr. Zahid Maleque MP, Minister for Health and Family Welfare, Government of the People’s Republic of Bangladesh during a simple ceremony at Health Ministry today.

Read more...

 

COVID-19 Update

Key points

  • Implementing all measures to ensure the health and safety of employees.
  • Beximco Pharma's manufacturing operations are currently unaffected; the Company is experiencing some disruption to its international distribution network and supply chain, but does not foresee any major shortage of raw materials in the immediate term.
  • Strong sales performance in the first three quarters of the financial year to 31 March 2020; the Company anticipates some impact in the fourth quarter; however, Beximco Pharma still expects to report year-on-year sales growth for the full year to 30 June 2020.
  • Reporting of Q3 financial results is delayed, as sanctioned by the Bangladesh Securities and Exchange Commission.

Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today provides a business update following the outbreak of COVID-19.

Bangladesh remains under lockdown, which was implemented on 25 March 2020, as the government sought to curb the spread of COVID-19. The government ordered the closure of all businesses and imposed restrictions on the movement of people and transport, except in exceptional circumstances, such as the provision of food and medicines, so the Company has been able to continue its operations.

Read more...

 

Beximco Group donate personal protective equipment to healthcare professionals in Bangladesh during COVID-19 pandemic

Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, in collaboration with its parent company Beximco Group, announces the donation of personal protective equipment (PPE) to healthcare professionals across Bangladesh following the outbreak of the COVID-19 pandemic.

Donate Personal Protective

As of 27 March 2020, Bangladesh has reported 48 cases of COVID-19 and 5 deaths as a result of the virus, with a number of people suspected of having COVID-19 under quarantine. Healthcare professionals are coming under increased pressure in their fight against this pandemic and, without the appropriate PPE, risk their own health when treating patients and conducting research.

Beximco Pharma will distribute PPE, which include protective gowns, face masks, gloves and goggles, in two phases:

In the first phase, the Company will distribute sufficient numbers of PPE to two testing centres (Institute of Epidemiology Disease Control And Research (IEDCR) and International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)) and government-designated hospitals for COVID-19 treatment (Kuwait Maitri Hospital, Kurmitola General Hospital, Bangladesh Railway Hospital in Kamlapur, Mahanagar General Hospital in Nayabazar, BAVS Maternity Hospital in Mirpur, Kamrangirchar 31-bed Hospital, Aminbazar 20-bed Hospital, and Jinjira 20-bed Hospital).

In the second phase, Beximco Pharma will expand distribution of PPE nationwide to more than 150 leading hospitals.

Read more...

 

Our uninterrupted supply of personal protective equipment (PPE)
to our front line healthcare professionals.

Providing PPE to Brig Gen Taufiqul Hasa Siddiquee, Commandant, Combined Military Hospital Dhaka.

Providing PPE to Brig Gen Jamil Ahmed, Director, Kurmitola General Hospital, Kurmitola, Dhaka Cantonment.

Providing PPE to Airforce Hospital.

Providing PPE and Medicines to one of the Director, ICDDR'B.

Providing PPE to the Director of DMCH.

Providing PPE to the Principal of DMCH.

Providing PPE to Prof. & Chairman AKM Akhtaruzzaman, Anaesthesia, Intensive Care and Pain Medicine, BSMMU.

Providing PPE to Aso. Prof. Md. Sattar Sarkar for Medicine Dept Sir Salimullah MCH.

Providing PPE to President & Secretary General of BMA.

Providing PPE to Dr. I.S.Abdul Ahad, Divisional Medical Officer (Incharge), Railway General Hospital, Kamalapur, Dhaka.

Providing PPE to the Director of Kuwait Bangladesh Friendship General Hospital, Uttara, Dhaka.

Providing PPE to Dr.Abul Hashem Sheikh, Asst.Director, Mugda Medical College Hospital, Dhaka.

 

Supporting Our People Nationwide!

Beximco Pharma is humble to announce that all Employees of Beximco Pharma Head Office (HO) and all employees of Nuvista Pharma Head Office (HO) have donated their one day’s salary for the humanity, who are suffering due to the situations emerged from COVID-19 and subsequent closed down.

 
News Feed

Beximco Launches First Remdesivir Generic :: Generics Bulletin

Bangladesh’s Beximco has claimed a world first with the launch of a generic version of remdesivir in its domestic market. Local authorities have granted an emergency use authorization for the COVID-19 treatment amid the coronavirus pandemic.

Read more...

Beximco Pharma introduces first generic remdesivir for COVID-19 :: Manufacturing chemist

Beximco Pharmaceuticals has announced the launch of remdesivir (under the brand name Bemsivir), an antiviral drug, which has been recently granted Emergency Use Authorization by the US FDA for the treatment of COVID-19. With this introduction, Beximco Pharma says it is the first company in the world to launch a generic version of remdesivir for the treatment of COVID-19.

Read more...

World First Copies of Gilead Virus Drug to Start Selling in Bangladesh :: Bloomberg

Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world.

Read more...

Bangladesh’s Beximco to begin producing COVID-19 drug remdesivir-COO :: This is MONEY WIRES

One of Bangladesh largest drugmakers, Beximco Pharmaceuticals Ltd, will start production this month of the experimental antiviral drug remdesivir, which has shown promise in fighting the new coronavirus, a senior company executive said on Tuesday.

Read more...

Exclusive: Bangladesh’s Beximco to begin producing COVID-19 drug remdesivir – COO :: metro

One of Bangladesh’s largest drugmakers, Beximco Pharmaceuticals, will start production this month of the experimental antiviral drug remdesivir, which has shown promise in fighting the new coronavirus, a senior company executive said on Tuesday.

Read more...

Bangladesh pharma giant to sell first generic version of remdesivir for Covid-19 :: Khaleej Times

One of Bangladesh’s largest drug-makers, Beximco Pharmaceuticals, says it has become the world's first company to start selling the generic version of Gilead Sciences Inc.'s anti-viral drug, remdesivir, which has shown promise in fighting the new coronavirus.

Read more...

Beximco Pharma Launched World’s First Generic Remdesivir :: GMP news

Beximco Pharmaceuticals announces the launch of remdesivir (under the brand name Bemsivir), an antiviral drug, for the treatment of COVID-19. With this introduction, Beximco Pharma is the first company in the world to launch a generic version of remdesivir for the treatment of COVID-19.

Read more...

Beximco Pharma launches first generic remdesivir for Covid-19 :: Pharmaceutical Technology

Bangladesh-based generic pharmaceuticals manufacturer Beximco Pharmaceuticals has launched the first generic version of antiviral drug remdesivir, originally developed by Gilead Sciences.

Read more...

First copies of Gilead’s Covid-19 drug to start selling in Bangladesh :: Hindustan times

Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world.

Read more...

Beximco introduces remdesivir for Covid-19 treatment :: The Daily Star

“Remdesivir is to be given free of cost to government hospitals,” Nazmul Hassan, managing director of Beximco Pharmaceuticals, today announced while launching Bemsivir (the brand name for remdesivir manufactured by Beximco Pharmaceuticals).

Read more...

Beximco to make remdesivir to treat COVID-19 :: The daily Observer

One of the country's largest drugmakers, Beximco Pharmaceuticals, will start production this month of the experimental antiviral drug remdesivir, which has shown promise in fighting the new coronavirus.

Read more...

Beximco Pharma launches world’s first generic Remdesivir for COVID-19 treatment :: The independent

Bangladesh’s pharmaceutical giant, Beximco Pharmaceuticals, on Thursday announced the launch of Remdesivir, an antiviral drug which has recently been given US FDA “Emergency Use Authorisation” for treatment of COVID-19 patients.

Read more...

First to produce in Bangladesh, Beximco will supply remdesivir for free to govt :: Dhaka Tribune

Beximco Pharmaceuticals, the first Bangladeshi drug manufacturer to introduce remdesivir in the local market, will supply the medicine for free to government hospitals dedicated for Covid-19 patients.

Read more...

Beximco Pharma introduces world’s first generic Remdesivir for COVID-19 treatment :: The Financial Express

Beximco Pharmaceuticals on Thursday announced the launch of Remdesivir, an antiviral drug which has recently been given US FDA “Emergency Use Authorisation” for treatment of COVID-19 patients.

Read more...

Beximco introduces COVID-19 drug remdesivir :: bdnews24

Beximco Pharmaceuticals has delivered the first batch of remdesivir, an antiviral drug which has recently been authorised by the US for emergency use in the treatment of COVID-19 patients, to the Ministry of Health and Family Welfare.

Read more...

 
TV News

 

Covid-19 Awareness Campaign

Thank you Doctor

Covid-19 Anxiety Pandemic